Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ:TELO
US Market
Holding TELO?
Track your performance easily

Telomir Pharmaceuticals, Inc. (TELO) Financial Statements

33 Followers

Telomir Pharmaceuticals, Inc. Financial Overview

Telomir Pharmaceuticals, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.647; its P/E ratio is -12.12; Telomir Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Sep 23Dec 22Dec 21
Income Statement-
Total Revenue----
Gross Profit----
EBIT$ -1.45M---
EBITDA$ -1.45M---
Net Income Common Stockholders$ -1.45M$ -1.71M--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.90M$ 2.45K$ 1.42K$ 0.00
Total Assets$ 2.10M$ 5.32M$ 48.73K-
Total Debt$ 0.00$ 1.34M$ 0.00$ 0.00
Net Debt$ -1.90M$ 1.34M$ -1.42K$ 0.00
Total Liabilities$ 534.15K$ 3.14M$ 986.01K$ 138.13K
Stockholders Equity$ 1.57M$ 2.18M$ -937.28K$ -138.13K
Cash Flow-
Free Cash Flow$ -1.60M---
Operating Cash Flow$ -1.60M---
Investing Cash Flow----
Financing Cash Flow$ 132.44K---
Currency in USD

Telomir Pharmaceuticals, Inc. Earnings and Revenue History

Telomir Pharmaceuticals, Inc. Debt to Assets

Telomir Pharmaceuticals, Inc. Cash Flow

Telomir Pharmaceuticals, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis